Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 363.73M P/E - EPS this Y 80.40% Ern Qtrly Grth -
Income -565.3M Forward P/E -36.05 EPS next Y 5.70% 50D Avg Chg -9.00%
Sales 1.19B PEG 0.14 EPS past 5Y 12.89% 200D Avg Chg -37.00%
Dividend N/A Price/Book 0.30 EPS next 5Y -25.30% 52W High Chg -78.00%
Recommedations 3.00 Quick Ratio 0.50 Shares Outstanding 52.40M 52W Low Chg 7.00%
Insider Own 1.88% ROA -0.38% Shares Float 51.70M Beta 1.24
Inst Own 74.78% ROE -60.57% Shares Shorted/Prior 7.13M/5.70M Price 7.21
Gross Margin 32.44% Profit Margin -47.69% Avg. Volume 1,447,854 Target Price 5.00
Oper. Margin 13.25% Earnings Date Aug 6 Volume 1,511,597 Change -8.85%
About Emergent Biosolutions, Inc.

Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States. The company offers NARCAN Nasal Spray for the emergency treatment of known or suspected opioid overdose; Vaxchora vaccine for the prevention of cholera; Vivotif vaccine for oral administration for the prevention of typhoid fever; Anthrasil for the treatment of inhalational anthrax; BioThrax, an anthrax vaccine; CYFENDUS for post-exposure prophylaxis of disease following suspected or confirmed exposure to Bacillus anthracis; and Raxibacumab injection for the treatment and prophylaxis of inhalational anthrax. It also provides ACAM2000, a smallpox vaccine; CNJ-016 to address complications from smallpox vaccination; TEMBEXA for the treatment of smallpox disease caused by variola virus in adult and pediatric patients; BAT for the treatment of symptomatic botulism; Ebanga for the treatment of Ebola; Reactive Skin Decontamination Lotion Kit to remove or neutralize chemical warfare agents from the skin; Trobigard, a atropine sulfate obidoxime chloride auto-injector. In addition, the company is developing CGRD-001 for the treatment of poisoning by organophosphorus nerve agents or organophosphorus compounds; EBS-LASV to prevent Lassa fever; EBS-MARV to prevent Marburg virus disease; EBS-SUDV to prevent Sudan virus disease; Pan-Ebola mAbs for the treatment of ebola virus; SIAN Antidote for initial treatment of certain or suspected acute cyanide poisoning; UniFlu for immunity against influenza A and B viruses; and WEVEE-VLP for equine encephalitis virus infections. Further, it provides contract development and manufacturing services comprising drug substance and product manufacturing, and packaging, as well as technology transfer, process, and analytical development services. The company was incorporated in 1998 and is headquartered in Gaithersburg, Maryland.

Emergent Biosolutions, Inc. News
05/10/24 Emergent BioSolutions to Hold Virtual Annual Meeting of Stockholders on Thursday, May 23, 2024
05/02/24 Q1 2024 Emergent BioSolutions Inc Earnings Call
05/02/24 Emergent BioSolutions Inc. (NYSE:EBS) Q1 2024 Earnings Call Transcript
05/02/24 Emergent BioSolutions Inc (EBS) (Q1 2024) Earnings Call Transcript Highlights: A Strong Start ...
05/01/24 PRESS DIGEST- Wall Street Journal - May 2
05/01/24 Emergent BioSolutions (EBS) Q1 2024 Earnings Call Transcript
05/01/24 Emergent BioSolutions Reports Surprising Q1 2024 Earnings, Exceeding Revenue and Net Income ...
05/01/24 Narcan-Maker Emergent BioSolutions to Cut 300 Jobs, Close Facilities
05/01/24 Emergent BioSolutions Reports First Quarter 2024 Financial Results
05/01/24 Emergent BioSolutions to lay off about 300 employees
05/01/24 UPDATE 2-Emergent BioSolutions to lay off about 300 employees
05/01/24 Emergent BioSolutions Announces Strategic Operational Changes to Stabilize Financial Position
05/01/24 Emergent BioSolutions Releases New Survey Findings Underscoring the Need to Continue Expanding Access & Increasing Awareness to Naloxone
04/30/24 Emergent BioSolutions Announces Amendment to its Existing Credit Facility
04/22/24 Emergent BioSolutions to Release First Quarter 2024 Financial Results & Conduct Conference Call on May 1, 2024
04/17/24 Institutional owners may take dramatic actions as Emergent BioSolutions Inc.'s (NYSE:EBS) recent 16% drop adds to one-year losses
04/01/24 Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive
03/28/24 Emergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN® Nasal Spray to Help Save Lives from the Ongoing Opioid Crisis
03/25/24 Emergent BioSolutions Receives NAI Status for Baltimore Bayview Manufacturing Facility
03/07/24 Emergent BioSolutions Inc (EBS) Reports Mixed Fourth Quarter and Full Year 2023 Financial Results
EBS Chatroom

User Image Polip Posted - 20 minutes ago

$XBI $IOVA $MIRM $EBS $VKTX the 10y has finally broke out the uptrend channel. Ready for the Bio bullish super cycle?

User Image NRG8 Posted - 1 hour ago

$EBS $EBS Nicely set up for gap up to $7-$8... ...or $10+ with first of expected newsflow (see list). $EBS Strong Buy $EBS Short term sp target: $15-$20 Medium term target: $40-$80... ...or acquisition target within 12 months with buyout price at $40 / share. .

User Image NRG8 Posted - 1 hour ago

@WinstonSmith33 Yes, nicely set up for gap up to $7-$8... ...or $10+ with first of expected newsflow (see list). $EBS Short term sp target: $15-$20 Medium term target: $40-$80... ...or acquisition target within 12 months with buyout price at $40 / share. .

User Image NRG8 Posted - 2 hours ago

@StockScanners $EBS Nicely set up for gap up to $7-$8... ...or $10+ with first of expected newsflow (see list). $EBS Short term sp target: $15-$20 Medium term target: $40-$80... ...or acquisition target within 12 months with buyout price at $40 / share.

User Image NRG8 Posted - 2 hours ago

@Rod92 Yes, nicely set up for gap up to $7-$8... ...or $10+ with first of expected newsflow (see list). $EBS Short term sp target: $15-$20 Medium term target: $40-$80... ...or acquisition target within 12 months with buyout price at $40 / share.

User Image WinstonSmith33 Posted - 3 hours ago

$EBS one day, one candle, gap up to 7$ imminent

User Image GoGetDontGetGot Posted - 4 hours ago

$EBS The pullback never happens when its convenient for you.... Investing 101. shouldn't have sold after earnings like a chump... i did it to myself.

User Image PattyBergeron Posted - 7 hours ago

$EBS congrats. I knew the play was under 2 to load up. I didn't have any funds at the time.

User Image Rod92 Posted - 7 hours ago

$EBS one of my best calls of the year. sold for a very nice profit, was expecting a pullback but damn this is just kassively undervalued and shorted that it can hit 20$ before we see a small pullback. anyways, putting my full position tomorrow at the open. long term by eoy this can easily hit 30-40$ based on my analysis. not pumping, real fundamentals and management back the price action. so many shorts need to be unloaded.

User Image StockScanners Posted - 9 hours ago

$EBS Still going strong. reached 5.85, needs to hold above 5.50

User Image billywilliamz Posted - 9 hours ago

$EBS imminent is $7.27

User Image Kawasaki1 Posted - 9 hours ago

$EBS Buy Out Imminent $JNJ

User Image zredpill Posted - 9 hours ago

$EBS l wouldn’t mind a healthy consolidation once we hit $6 and change. This thing has been a monster the past couple weeks.

User Image JerzeyDevil Posted - 9 hours ago

$EBS Drop some juicy news Papa! Let’s go!

User Image ValleyCapital Posted - 11 hours ago

$EBS it’s crazy that none of the BPs have snatched this?? Why? Can anyone answer?

User Image ComradeKomisar Posted - 11 hours ago

$EBS Ooof: Narcan product placement on PragerU. https://youtu.be/KazKFCE6YaU?t=2505

User Image BullRush247 Posted - 11 hours ago

$EBS Good

User Image Stocksinmydrawers Posted - 11 hours ago

$EBS nice

User Image venusmars Posted - 13 hours ago

$EBS strong finish today ..steadily moving up

User Image NRG8 Posted - 13 hours ago

$EBS Nicely set up for gap up to $7-$8... ...or $10+ with first of expected newsflow (see list). $EBS Short term sp target: $15-$20 Medium term target: $40-$80... ...or acquisition target within 12 months with buyout price at $40 / share. .

User Image GrantDiaz Posted - 13 hours ago

$EBS Good chance it's over $6 tomorrow.

User Image ComradeKomisar Posted - 14 hours ago

$EBS PSA for Shorty

User Image ComradeKomisar Posted - 14 hours ago

$EBS Sounds like that's the plan.

User Image olddumper Posted - 14 hours ago

$EBS some news would be amazing. I sold all my $5 strikes but keep some $7.5 lottos open. This is already very strong if they drop some news near expiry it could be fireworks.

User Image 704Dame Posted - 14 hours ago

$EBS should see a good size pullback tomorrow..

User Image SPACdeORO Posted - 15 hours ago

$EBS

User Image WinstonSmith33 Posted - 15 hours ago

$EBS yes and no. It looks like someone already knows

User Image Westcoastcrippler Posted - 15 hours ago

$EBS Still no watchers. Open ex Friday. Pullback would be healthy.

User Image ComradeKomisar Posted - 15 hours ago

@SolarWind99 option chain says $EBS hits $10 in December. I say June / July.

User Image zawojak Posted - 15 hours ago

$ARQT BTW hold this stock, after yoh sell it will go up to $15. I bought $EBS at $2.50 then sold at $2.30 after I sold it went up to $5.70 ...HOLD

Analyst Ratings
Benchmark Buy Apr 11, 24
Benchmark Buy Mar 7, 24
Benchmark Hold Aug 29, 23
Benchmark Buy May 31, 23
Benchmark Buy May 19, 23
Benchmark Buy Apr 10, 23
JP Morgan Underweight Mar 17, 23
Benchmark Hold Nov 10, 22
Chardan Capital Buy Nov 9, 22
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Zoon Kathryn C Director Director May 25 Sell 8.37 3,530 29,546 49,971 07/24/23
Richard Ronald Director Director Nov 25 Sell 11.94 1,912 22,829 19,837 11/29/22
Havey Adam EVP, Business Operat.. EVP, Business Operations Mar 03 Option 40.14 37,279 1,496,379 58,335 03/03/21
Havey Adam EVP, Business Operat.. EVP, Business Operations Mar 03 Sell 99.32 37,279 3,702,550 38,190 03/03/21
Kramer Robert President and CEO President and CEO Feb 09 Option 30.75 45,397 1,395,958 152,210 02/09/21
Kramer Robert President and CEO President and CEO Feb 09 Sell 120.03 45,397 5,449,002 139,210 02/09/21
Kramer Robert President and CEO President and CEO Jan 19 Option 25.62 19,026 487,446 158,236 01/19/21
Kramer Robert President and CEO President and CEO Jan 19 Sell 106.01 19,026 2,016,946 139,210 01/19/21
El-Hibri Fuad Chairman Chairman Nov 12 Option 26.45 39,391 1,041,892 1,143,379 11/12/20
El-Hibri Fuad Chairman Chairman Nov 12 Sell 91.74 39,391 3,613,730 1,123,988 11/12/20
El-Hibri Fuad Chairman Chairman Nov 04 Option 26.45 40,000 1,058,000 1,143,988 11/04/20
El-Hibri Fuad Chairman Chairman Nov 04 Sell 90.59 40,000 3,623,600 1,123,988 11/04/20
El-Hibri Fuad Chairman Chairman Sep 25 Sell 99.72 25,535 2,546,350 1,123,988 09/25/20
El-Hibri Fuad Chairman Chairman Sep 18 Sell 101.58 40,000 4,063,200 1,149,523 09/18/20
El-Hibri Fuad Chairman Chairman Sep 11 Sell 102.73 40,000 4,109,200 1,189,523 09/11/20
SULLIVAN LOUIS W Director Director Sep 04 Option 20.08 7,893 158,491 50,655 09/04/20
SULLIVAN LOUIS W Director Director Sep 04 Sell 111.22 28,418 3,160,650 42,762 09/04/20